Evidence map›Paper›PMID 42591528›Full record

ArticleTranslational cancer research2026

A comparative analysis of clinical and sonographic features: cutaneous melanoma and melanocytic nevi.

Wanli Ye, Yongrui Wang, Hongyan Liu, Yong Jiang, Xingheng Wang, Li Qiu, Yuanjiao Tang

Abstract read
In one paragraph

Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wanli Ye *Department of Medical Ultrasound, West China Hospital of Sichuan University, Chengdu, China.
Yongrui Wang *Department of Medical Ultrasound, West China Hospital of Sichuan University, Chengdu, China.
Hongyan LiuDepartment of Medical Ultrasound, West China Hospital of Sichuan University, Chengdu, China.
Yong JiangDepartment of Pathology, West China Hospital of Sichuan University, Chengdu, China.
Xingheng WangDepartment of Medical Ultrasound, West China Hospital of Sichuan University, Chengdu, China.
Li QiuDepartment of Medical Ultrasound, West China Hospital of Sichuan University, Chengdu, China.
Yuanjiao TangDepartment of Medical Ultrasound, West China Hospital of Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cutaneous melanoma (CM) ranks among the most lethal skin malignancies, with its global incidence rising steadily. Cutaneous melanocytic nevi (CMN), by contrast, are common benign lesions that rarely undergo malignant transformation. Despite their divergent biological behaviors, CM and CMN frequently present with overlapping clinical and ultrasonographic features, rendering preoperative distinction challenging. In this study, we aim to investigate and compare the clinical and sonographic characteristics of CM and CMN. Methods: This retrospective analysis included nine cases of CM, 11 cases of compound nevi, and 22 cases of intradermal nevi, all examined by ultrasound and confirmed by postoperative histopathology. Clinical and sonographic features were compared among the three groups, including gender, age, lesion location, depth, maximum diameter, margin, morphology, hyperechoic spots, posterior acoustic enhancement, lateral acoustic shadow, and color Doppler flow imaging (CDFI) grade. Differences were evaluated between CM and CMN groups, as well as among the three groups. Results: (I) Significant differences (all P<0.05) were found between CM and CMN groups for eight features: patient age, lesion location, depth, maximum diameter, margin, morphology, posterior acoustic enhancement, and CDFI grade. (II) Receiver operating characteristic (ROC) curve analysis showed that patient age exhibited excellent performance in distinguishing CM from CMN (sensitivity 88.9%, specificity 97.0%, and an area under the curve (AUC) 0.928 [95% confidence interval (CI): 0.798-1.000]). Maximum diameter also demonstrated good discriminatory value [sensitivity 77.8%, specificity 81.8%, AUC 0.882 (95% CI: 0.763-1.000)]. When combined, age and maximum diameter achieved optimal performance [sensitivity 88.9%, specificity 100%, AUC 0.929 (95% CI: 0.796-1.000); all P<0.05]. (III) The same eight features also showed significant intergroup differences across the three diagnostic groups (all P<0.05). (IV) ROC analysis indicated that maximum diameter offered moderate diagnostic value in differentiating compound nevi from intradermal nevi [sensitivity 63.6%, specificity 68.2%, AUC 0.661 (95% CI: 0.467-0.855)]. Conclusions: CM predominantly occurs in elderly individuals on the extremities. Ultrasonographically, CM is characterized by involvement of the full-thickness dermis and subcutaneous layer, a maximum diameter of ≥1 cm, poorly defined margins, an irregular or slightly irregular morphology, posterior acoustic enhancement, and abundant blood flow signals. Conversely, CMN predominantly affects younger individuals, most frequently on the head, neck, and face. On ultrasound, compound nevi typically involve the superficial dermis, while intradermal nevi most commonly involve the full-thickness dermis. Both types of CMN exhibit a maximum diameter of <1 cm, relatively well-defined margins, relatively regular morphology, absence of posterior acoustic enhancement, and non-abundant blood flow signals. The combination of age and maximum diameter significantly enhances specificity in distinguishing CM from CMN. Maximum diameter alone offers some value in differentiating compound nevi from intradermal nevi.

Indexed as

clinical characteristicsmelanocytic nevi (MN)Melanomasonographic features

Identifiers

PMID42591528
PMCPMC13462119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.